Surgimate Raises Significant Strategic Investment From Banneker Partners To Accelerate Growth & Disrupt Surgical Coordination
PRIVATESep 20, 2022
Round Type
Corporate Round
New YorkInformation TechnologyBiotechnologySoftwareHealth CareMedicalMedical Device
Description
Surgimate, the leading provider of surgical coordination software in the U.S., today announced a significant investment by San Francisco-based investment firm, Banneker Partners. Since 2010, Surgimate has been transforming the surgical workflow at surgical practices nationwide by increasing operational efficiency, reducing surgical cancellations, and improving the quality of care for patients across all surgical specialties.
Who to call at Surgimate, and when
A new round usually means Surgimate is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Surgimate raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Surgimate, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Surgimate
Location
New York, New York, United States
About
Surgimate is a leading provider of surgical coordination software in the U.S., enabling surgical practices to increase volume, reduce cancellations and achieve sustainable growth. Headquartered in New York with R&D offices in Israel, Surgimate facilitated more than 750,000 surgical events across 100+ practices in 2024 alone. With innovative tools for surgical project management, reporting, form generation and more, Surgimate empowers surgical teams to operate efficiently and deliver exceptional care.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Surgimate raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.